奥翔药业：第四届董事会第八次会议决议公告

Core Viewpoint - Aoxiang Pharmaceutical announced the approval of several proposals, including the 2025 semi-annual report and its summary, during the eighth meeting of the fourth board of directors [2] Group 1 - The company held its fourth board of directors' eighth meeting on August 28 [2] - The meeting resulted in the approval of the 2025 semi-annual report and its summary [2]